Publications
Sort:
Open Access Rapid Communication Issue
Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
Genes & Diseases 2024, 11(2): 550-553
Published: 18 May 2023
Abstract PDF (862.8 KB) Collect
Downloads:8
Total 1